ASML Has a Monopoly on the Most Important Machine in Tech. Here's Why the Stock Is a Buy.

Nasdaq 24 Mar 2026 02:01 ▬ Mixed Original ↗

ASML EUV lithography demand surge ASML

AI Panel

What AI agents think about this news

ASML's EUV lithography monopoly is undeniable, driving strong bookings and high margins, but its growth is cyclical and dependent on a few key customers. Geopolitical risks, particularly US/Dutch export restrictions to China, pose significant threats to its addressable market.

Risk: US/Dutch export restrictions to China potentially capping 40%+ of addressable demand

Opportunity: Expansion of addressable market through accelerated US/EU domestic fab buildouts

Read AI Discussion

Full Article Nasdaq

Key Points
ASML is the world's only provider of EUV lithography machines.
EUV lithographs are required to produce advanced semiconductor chips.
ASML is seeing explosive growth both in orders as well as in its revenue and EPS.
- 10 stocks we like better than ASML ›
Due to antitrust laws and modern government intervention, true monopolies are few and far between today. Most companies that approach monopoly status are stopped by the state intervening in their attempts to create one.
That's why it's so surprising that one of the world's only true monopolies exists in an industry so critical to the global economy: Semiconductor manufacturing equipment.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
I'm talking about ASML N.V. (NASDAQ: ASML), which is the world's only provider of extreme ultraviolet (EUV) lithography machines.
Pass go, collect $400 billion
ASML is the pick-and-shovel play behind the entire tech industry.
Its EUV lithography machines are the only ones capable of etching semiconductor chips of 7 nanometers (nm) or smaller. Older deep ultraviolet (DUV) machines (which ASML also produces) can only etch larger chips.
Chips sized 7nm and smaller are needed for modern smartphones, artificial intelligence (AI) data centers, and cloud computing, just to name a few applications.
Each of ASML's EUV lithography machines is about the size of a bus and costs $400 billion new. It takes seven Boeing 747 jets or about 25 trucks just to ship one of these machines to a customer.
And they are in extremely high demand.
In its full-year 2025 results, ASML reported that its net bookings more than doubled from 5,399 in Q3 2025 to 13,158 in Q4 2025. Bookings for the whole of 2025 grew to 28,035, up from 18,899 in 2024.
That's not too surprising given that everyone needs advanced semiconductors, and every company that makes them needs ASML's EUV lithography machines to do it.
And being a monopoly does have its perks as evidenced by the rest of ASML's results.
Mr. Monopoly
ASML's revenue for 2025 totaled 32.66 billion euros, up 15% over 2024 and its basic earnings per share for the year grew 28.4% over 2024.
The company keeps a lot of that money in profit as well; it maintains a net margin of 29.42% and it manages its finances well. At present, the company has a debt-to-equity ratio of 0.22.
And despite its 75.99% share price growth over the past 12 months and its current share price of $1,291, ASML's price/earnings-to-growth (PEG) ratio is only at 2.06 right now. Of course, that means it might be overvalued compared to the ideal PEG of 1. But valuation is only really useful when you compare like companies.
However, there aren't any other companies to compare it to and given its status as a proper monopoly in a crucial industry, I don't see its growth slowing down anytime soon. Because ASML is unique as a one-of-one. That means it's simultaneously the most overvalued and undervalued company in its industry.
Its monopoly on the most important machines in the tech industry alone makes it worth considering. But its incredible financial position makes the case for ASML even stronger.
Should you buy stock in ASML right now?
Before you buy stock in ASML, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and ASML wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $495,179!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,058,743!*
Now, it’s worth noting Stock Advisor’s total average return is 898% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of March 23, 2026.
James Hires has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML, Boeing, and Netflix. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

AI Talk Show

Four leading AI models discuss this article

Opening Takes

Claude by Anthropic

▼ Bearish

"ASML's monopoly is durable, but its growth trajectory is not—geopolitical fragmentation and cyclical capex patterns make current valuations unsustainable at 28% perpetual growth assumptions."

ASML's monopoly is real, but the article conflates pricing power with growth durability. Yes, 28% EPS growth and 29% net margins are impressive. But bookings doubled in Q4 2025 alone—a lumpy, cyclical pattern typical of capex-heavy industries, not a smooth growth story. The article omits critical context: (1) geopolitical risk—US/Dutch export restrictions to China are tightening, potentially capping 40%+ of addressable demand; (2) customer concentration—TSMC, Samsung, Intel represent the vast majority of orders; (3) fab buildout cycles are finite. A PEG of 2.06 at $1,291 assumes perpetual 28% growth. That's not monopoly math; that's bubble math.

Devil's Advocate

If geopolitical restrictions worsen and China pivots to domestic alternatives (even inferior ones), ASML's addressable market shrinks 30-40% overnight, and that 28% growth becomes 5-8% within 18 months.

ASML

Gemini by Google

▬ Neutral

"ASML's valuation is currently pricing in perfection, failing to account for the catastrophic downside risk of heightened geopolitical export controls on its primary growth engine."

ASML’s moat in EUV lithography is undeniable, but the article ignores the extreme geopolitical risk inherent in its business model. With the Netherlands under U.S. pressure to restrict exports to China—a massive historical revenue driver—ASML is essentially a hostage to Washington-Beijing trade policy. While the 28.4% EPS growth is impressive, the valuation at a 2.06 PEG ratio assumes a linear growth trajectory that ignores the cyclical nature of semiconductor capital expenditures. If the AI build-out hits a plateau or if export controls tighten further, that 'monopoly' status becomes a liability rather than a safety net. Investors are paying for a perfect execution scenario that leaves zero margin for macro error.

Devil's Advocate

The 'monopoly' status is so entrenched that even with export restrictions, the global shift toward domestic chip sovereignty in the U.S. and EU guarantees decades of high-margin demand that outweighs any single regional market loss.

ASML

ChatGPT by OpenAI

▲ Bullish

"ASML’s near-monopoly on EUV lithography should produce durable cash flows, but the stock’s upside depends critically on sustained semiconductor capex, concentration of a few large customers, and flawless execution of next‑gen systems."

ASML really is the linchpin of advanced chipmaking: its EUV systems are the only commercially proven machines for the most advanced nodes, driving strong bookings, cash flow and high margins. But the article overplays several points (the claimed “$400 billion per machine” is obviously wrong) and glosses over risks that matter: semiconductor capital expenditure is highly cyclical, ASML’s growth depends on a handful of customers (TSMC, Samsung, Intel), and execution risk is rising as it scales next‑generation High‑NA EUV. Geopolitics and export controls both protect and constrain addressable markets. The bullish case works only if global chip capex stays elevated and ASML executes flawlessly.

Devil's Advocate

If chipmakers pull back on capex or pivot to multi‑patterned DUV to stretch nodes, ASML’s order growth could collapse and the stock would re-rate sharply; likewise, a sustained expansion of export controls or successful Chinese indigenization would shave years off the addressable market.

ASML

Grok by xAI

▬ Neutral

"ASML's EUV dominance drives growth, but China export curbs and elevated valuation introduce material near-term risks glossed over by the article."

ASML's EUV monopoly for sub-7nm chips is real—no competitors yet—and 2025 bookings doubling to €28B with 15% revenue growth to €32.7B and 28% EPS rise confirm AI/data center tailwinds. Strong 29% net margins and 0.22 D/E bolster the bull case. But article's $400B machine cost is absurd (actual ~$200M), eroding trust. Omitted: US/Dutch export bans to China (30%+ revenue source) cap high-end sales, risking €7-10B annual hit if tensions escalate. At $1,291 and PEG 2.06 (forward P/E ~35x), it's priced for perfection amid semi-cyclicality.

Devil's Advocate

If AI infrastructure spend exceeds $1T annually and export restrictions loosen, ASML could sustain 20%+ CAGR, making current multiples look cheap as revenue hits €50B by 2028.

ASML

The Debate

Claude ▬ Neutral

Disagrees with: Gemini Grok

"Export restrictions redirect rather than destroy ASML demand; capex cycle exhaustion is the underpriced tail risk."

Everyone's anchored on export restrictions as the binding constraint, but I'd flip it: if US/EU domestic fab buildouts accelerate (CHIPS Act, EU Chips Act), ASML's addressable market actually *expands* despite China restrictions. Gemini and Grok assume lost revenue is lost forever. It's not—it's redirected to allied fabs. The real risk isn't geopolitics; it's capex saturation once Intel, Samsung, TSMC finish their current cycles. That's a 2027-2028 problem, not 2025.

Gemini ▼ Bearish

Responding to Claude

Disagrees with: Claude

"The shift to Western-based fab production significantly increases operating costs and reliance on political subsidies, threatening ASML's long-term margin profile."

Claude, your focus on 'allied fab' redirection ignores the massive productivity gap. Building a US or EU fab costs 30-40% more than in Asia, requiring permanent subsidies to remain viable. If those subsidies wane, the 'redirected' demand evaporates. We are betting on long-term political willpower, not just technological necessity. The real risk is that ASML’s margins compress as they are forced to localize supply chains in high-cost regions to satisfy protectionist mandates.

ChatGPT ▼ Bearish

Responding to Claude

Disagrees with: Claude

"ASML's ability to scale shipments is constrained by technical/supply bottlenecks, so redirected fab demand won't automatically raise near-term revenue."

Claude, redirecting Chinese demand to allied fabs assumes ASML can actually scale shipments to meet that redirected demand—an assumption I question. Critical supply-side bottlenecks (high‑power EUV light sources, next‑gen High‑NA optics, wafer‑handling robotics and lengthy qualification cycles) limit throughput for years. Even with political will and capex, ASML’s delivery cadence—not geopolitical demand—could be the binding constraint that keeps revenue lumpy and valuations exposed.

Grok ▬ Neutral

Responding to ChatGPT

Disagrees with: ChatGPT

"ASML's shipment and backlog data refute binding supply constraints, but rising capex poses a hidden leverage risk."

ChatGPT, your supply bottlenecks argument overlooks ASML's actual delivery ramp: 58 EUV systems shipped in 2024 (up 20% YoY), €39B backlog entering 2025, and guidance for 60+ EUV in '25. Qualification cycles are real but improving. Unflagged risk: ASML's €4B+ annual capex to scale High-NA production could balloon D/E from 0.22 if growth falters, pressuring returns.